Pipeline
Pipeline Status in NEORNAT
| Modality | Project | Indication | Discovery | In vivo efficacy | Non Clinical | IND Approval | Phase 1 |
|---|---|---|---|---|---|---|---|
| antisense miRNA | NRT-YHD_001 | HCC | 2026’ 4Q | ||||
| NRT-FX_01 | MASH/ Liver fibrosis |
||||||
| NRT-YHD_002 | Lung cancer |
||||||
| NRT-YHD_003 | Pancreatic cancer |
||||||
| siRNA | NRT-NMJ_001 | HCC | |||||
| NRT-NMJ_002 | Lung cancer |
||||||
| protein marker |
NRT-GCDM | Gastric cancer |
|||||
| NRT-LCDM | HCC |